Kenichiro Nagai
Fukushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Analysis of PTPRZ expression in glioma and schwannoma - PTPRZ-long is highly expressed and shed in glioma.
Journal: Biochemical and biophysical research communications
Published: October 28, 2025
Cerebrospinal fluid soluble protein tyrosine phosphatase receptor type Z detected with human natural killer-1 antibody as a practical biomarker for glioma diagnosis.
Journal: Neuro-oncology advances
Published: September 19, 2025
Bifocal germ cell tumor of pineal germinoma and neurohypophyseal embryonal carcinoma: illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: December 04, 2023
Schwannoma, Neurofibromatosis Type 2, and Schwannomatosis in the 2021 WHO Classification of Tumors of the Central Nervous System
Journal: No shinkei geka. Neurological surgery
Published: September 24, 2023
Endoscopic Endonasal Approach for Optic Canal Dural Metastasis in a Patient with Progressive Visual Dysfunction: A Case Report.
Journal: NMC case report journal
Published: September 14, 2023
Brain-specific glycosylation enzyme GnT-IX maintains levels of protein tyrosine phosphatase receptor PTPRZ, thereby mediating glioma growth.
Journal: The Journal of biological chemistry
Published: January 22, 2023
Protein Tyrosine Phosphatase Receptor Type Z in Central Nervous System Disease.
Journal: International journal of molecular sciences
Published: February 26, 2022
Soluble protein tyrosine phosphatase receptor type Z (PTPRZ) in cerebrospinal fluid is a potential diagnostic marker for glioma.
Journal: Neuro-oncology advances
Published: July 10, 2020
A Case of Percutaneous Thrombectomy for Internal Carotid Artery Occlusion due to In-Stent Thrombosis Following Stent-Assisted Intra-Aneurysmal Embolization.
Journal: Journal of neuroendovascular therapy
Published: May 13, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026